Resolian Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
500
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
- Investments
-
2
Resolian General Information
Description
Operator of a contract research organization specializing in small and large molecules. The company offers services in drug metabolism and pharmacokinetics and bioanalytical, new drugs, metabolites or generic drug assays, large molecule immunoassays, small molecule metabolite profiling and identification and biosimilar characterization, thereby assisting clients through the process of taking a drug from pre-clinical trials to market at earliest.
Contact Information
Website
www.resolian.comCorporate Office
- 17 Lee Boulevard
- Malvern, PA 19355
- United States
Corporate Office
- 17 Lee Boulevard
- Malvern, PA 19355
- United States
Resolian Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Resolian Comparisons
Industry
Financing
Details
Resolian Competitors (11)
One of Resolian’s 11 competitors is BPS Bioscience, a Corporation company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BPS Bioscience | Corporation | San Diego, CA | ||||
| AbCellera Biologics | Formerly VC-backed | Vancouver, Canada | ||||
| Theorem Clinical Research | Formerly PE-Backed | King of Prussia, PA | ||||
| Sygnature Discovery | Private Equity-Backed | Nottingham, United Kingdom | ||||
| Symeres | Private Equity-Backed | Nijmegen, Netherlands |
Resolian Signals
Resolian Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Resolian Investments & Acquisitions (2)
Resolian’s most recent deal was a Merger/Acquisition with Denali Medpharma. The deal was made on 01-Nov-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Denali Medpharma | 01-Nov-2023 | Merger/Acquisition | BPO/Outsource Services | ||
| LGC (Drug Development Solutions Business) | 01-Jul-2022 | Buyout/LBO | Laboratory Services (Healthcare) |
Resolian Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Denali Medpharma | Chongqing, China | 2017 |
Resolian FAQs
-
When was Resolian founded?
Resolian was founded in 2008.
-
Where is Resolian headquartered?
Resolian is headquartered in Malvern, PA.
-
What is the size of Resolian?
Resolian has 500 total employees.
-
What industry is Resolian in?
Resolian’s primary industry is BPO/Outsource Services.
-
Is Resolian a private or public company?
Resolian is a Private company.
-
What is Resolian’s current revenue?
The current revenue for Resolian is .
-
Who are Resolian’s investors?
Kohlberg Kravis Roberts and Ampersand Capital Partners have invested in Resolian.
-
Who are Resolian’s competitors?
BPS Bioscience, AbCellera Biologics, Theorem Clinical Research, Sygnature Discovery, and Symeres are some of the 11 competitors of Resolian.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process